Titre : | Can psychiatry cross the quality chasm? Improving the quality of health care for mental and substance use conditions (2007) |
Titre traduit : | (La psychiatrie peut-elle franchir le gouffre de la qualité ? Améliorer la qualité des soins de santé dans les situations mentales et d'usage de substances.) |
Auteurs : | H. A. PINCUS ; A. E. PAGE ; DRUSS B. ; P. S. APPELBAUM ; G. GOTTLIEB ; M. J. ENGLAND |
Type de document : | Article : Périodique |
Dans : | American Journal of Psychiatry (Vol.164, n°5, May 2007) |
Article en page(s) : | 712-719 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés PSYCHIATRIE ; DISPOSITIF DE SOIN ; QUALITE DES SOINS ; PSYCHOPATHOLOGIEThésaurus géographique ETATS-UNIS |
Résumé : | In 2001, a seminal Institute of Medicine report, Crossing the Quality Chasm: A New Health System for the 21st Century, put forth a comprehensive strategy for improving the quality of U.S. health care. This strategy attained considerable traction within the overall U.S. health care system and subsequent attention in the mental health community as well. A new Institute of Medicine report, Improving the Quality of Health Care for Mental and Substance Use Conditions, examines the quality chasm strategy in light of the distinctive features of mental and substance use health care, including concerns about patient decision-making abilities and coercion into care, a less developed quality measurement and improvement infrastructure, lagging use of information technology and participation in the development of the National Health Information Infrastructure, greater separations in care delivery accompanied by more restrictions on sharing clinical information, a larger number of provider types licensed to diagnose and treat, more solo practice, and a differently structured marketplace. This article summarizes the Institute of Medicine's analysis of these issues and recommendations for improving mental and substance use health care and discusses the implications for psychiatric practice and related advocacy efforts of psychiatrists, psychiatric organizations, and other leaders in mental and substance use health care. (Author' s abstract) |
Domaine : | Plusieurs produits / Several products |
Sous-type de document : | Revue de la littérature / Literature review |
Refs biblio. : | 41 |
Affiliation : |
Department of Psychiatry, Columbia University, and New York Presbyterian Hospital, New York, NY 10032. Etats-Unis. United States. |
Numéro Toxibase : | 1302123 |
Centre Emetteur : | 13 OFDT |
Cote : | A03291 |
Accueil